MDI Bio Lab scientists discovered how zebrafish solve a basic challenge in regenerative biology—insights in their newest publication in the journal Development could one day guide human repair.

The Phase III study FIND-CKD ( NCT05047263) — investigating the efficacy and safety of KERENDIA ® (finerenone) versus placebo when added to standard of care in adult patients with non-diabetic chronic ...

Dennis Moledina encountered a common problem during his training in nephrology, the specialty dedicated to kidney health.

Scientists report significant progress in cultivating nephron progenitor cells (NPCs), the cells destined to form the kidney's filtration system, the nephrons. NPCs hold immense promise for ...

The world is experiencing a hidden epidemic with kidney disease. More than 850 million people worldwide have some form of ...

Kerendia has hit the spot in another phase 3 trial that could extend its use as a treatment for patients with chronic kidney disease (CKD). Extending the label for Kerendia is a strategic priority for ...

Our kidneys, two bean-shaped organs nestled below the rib cage, are often unsung heroes of our bodies. While their most recognised function is producing urine to filter waste, their roles extend far ...